For HCPsIntended for HCPs.
All Authors
AK

Neurology

Dr. Aditi Kulkarni

Recent Articles

13 total

Neurology

FDA Approves Donanemab for Alzheimer: 27% Cognitive Decline Reduction

FDA approves donanemab for Alzheimer: 27% cognitive decline reduction in mild AD patients.

Apr 30, 2026|3 min read|FDA

Neurology

CGRP Inhibitors: Erenumab, Fremanezumab, Galcanezumab, and Atogepant for Migraine Prevention

CGRP inhibitors like erenumab and fremanezumab show significant efficacy in migraine prevention, reducing attack frequency effectively.

Apr 30, 2026|3 min read|WHO

Neurology

FDA Approves Atogepant for Episodic Migraine Prevention: 50% Reduction in Monthly Migraine Days

Atogepant (Qulipta) approved for episodic migraine prevention: 50% reduction in monthly migraine days.

Apr 29, 2026|3 min read|NEJM

Neurology

Ofatumumab and Natalizumab: High Efficacy Options for Multiple Sclerosis in 2025

Ofatumumab and natalizumab show high efficacy in multiple sclerosis treatment: 50% and 68% reduction in relapse rates and disability progression.

Apr 29, 2026|3 min read|NEJM

Neurology

FDA Approves Lecanemab for Alzheimer: 27% Cognitive Decline Reduction

FDA approves lecanemab for Alzheimer: 27% cognitive decline reduction in early-stage patients confirmed by amyloid PET.

Apr 27, 2026|3 min read|NEJM

Neurology

CGRP Inhibitors: Erenumab, Fremanezumab, Atogepant, and Rimegepant for Migraine Prevention

CGRP inhibitors reduce migraine days significantly. Erenumab, fremanezumab, atogepant, and rimegepant are key options for prevention.

Apr 27, 2026|3 min read|NEJM

Medical Research

Type 2 Diabetes Linked to Faster Chronic Disease Onset

New research reveals type 2 diabetes accelerates development of multiple chronic diseases, particularly in middle-aged adults, impacting patient outcomes and treatment plans.

Apr 23, 2026|4 min read|Medical Xpress

Medical Research

Emotional Eaters Less Likely to Lose Weight on GLP-1 Therapy

Research reveals individuals who overeat for emotional reasons may have reduced weight loss success with GLP-1 receptor agonists like Ozempic.

Apr 19, 2026|4 min read|Medical Xpress

Healthcare Business

Reduce Mental Fatigue in Hearing Loss Patients by 30%

Discover how addressing hearing loss can improve mental health outcomes, reducing social isolation, anxiety, and depression in patients.

Apr 18, 2026|7 min read|American Journal Managed Care

Neurology

Boost Neurology Dept Efficiency with Effective Vice Chair Roles

Discover how evolving vice chair responsibilities can enhance neurology department leadership, faculty engagement, and alignment with institutional goals.

Apr 4, 2026|2 min read|Neurology Live

Health Information

Accurate RA Diagnosis in Less Time

Learn how lab tests and imaging help doctors diagnose rheumatoid arthritis quickly and accurately, reducing diagnostic time and improving patient outcomes.

Apr 2, 2026|6 min read|MedlinePlus

Medical Devices

Boost Breast Cancer Survival Rates with Latest Treatments

Discover how advances in breast cancer treatment are improving patient outcomes and survival rates, offering new hope for individuals diagnosed with the disease.

Mar 30, 2026|6 min read|Medical Device News Magazine